Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition.
about
Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeastIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesMembrane transporters in drug developmentUnderstanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesMechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytesTreatment heterogeneity in asthma: genetics of response to leukotriene modifiers.Inhibition of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Regulates the Hepatobiliary Excretion and Plasma Exposure of Thienorphine and Its Glucuronide Conjugate.Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery.Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics.Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.An evaluation of the latest in vitro tools for drug metabolism studies.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Review of Transporter-Related Postmarketing Requirement or Postmarketing Commitment Studies.Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol.Lack of interaction between the peptidomimetic substrates captopril and cephradine.Dietary pectin up-regulates monocaboxylate transporter 1 in the rat gastrointestinal tract.Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.
P2860
Q21245306-8ECFE9CE-05B6-4B48-8A7F-E9BB9E43CCADQ28388335-6DEEB0D7-0C93-4729-98FD-B38CBC5CBEEDQ29616802-105C5079-854B-48CF-8B04-EAD7EC7FD00CQ33683206-9208E87F-4CB1-41E7-98AB-7445B0A91230Q34378865-FFC029EC-E647-4FB4-A8DF-924018B538D1Q34646772-4AEB4E17-D3DE-4766-9D3B-D96E40CA3F35Q35579531-2ED03C9C-7FF0-440C-BDC1-828E3B22A36EQ36775615-08FE5553-7385-499D-98E1-06DDA0910C73Q37159255-6FFCB660-D7E0-46BF-963E-339F5A8F6123Q37824864-D5AAF22C-D4C4-4414-A218-6406CF63A6B4Q37969214-E1A29DDB-A796-4BD6-9D3D-A9578DDD70CEQ37993631-E16CDD4A-AA3B-4521-B1D1-665EBA90F8D3Q38160881-269C7F97-AD91-40D7-AB03-616A2E274C43Q38888350-DEAB1B4E-E230-4065-92A1-B3AF2DBA921EQ38888355-65BF4BBD-FE9C-4F0F-A01E-E7366BD9A9C0Q41873787-6B774D42-5F16-448B-BFCE-3DBAF8F589F1Q46107324-B1B779E6-D836-4EA1-BFC1-24140DEA210FQ46147889-EA92CDF5-5174-4DA0-90E1-98FEFC7F4776Q51050124-731B3B46-ECA3-4F32-94B0-C75157701F45
P2860
Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Biochemical and molecular phar ...... erminants of drug disposition.
@ast
Biochemical and molecular phar ...... erminants of drug disposition.
@en
type
label
Biochemical and molecular phar ...... erminants of drug disposition.
@ast
Biochemical and molecular phar ...... erminants of drug disposition.
@en
prefLabel
Biochemical and molecular phar ...... erminants of drug disposition.
@ast
Biochemical and molecular phar ...... erminants of drug disposition.
@en
P356
P1476
Biochemical and molecular phar ...... erminants of drug disposition.
@en
P2093
Yoshimichi Sai
P356
10.2133/DMPK.20.91
P577
2005-04-01T00:00:00Z